Beyond cardiovascular diseases and neurodegenerative disorders, the CCL2-CCR2 signaling pathway has been implicated in several other aging-related conditions, including chronic inflammation in skeletal muscle, adipose tissue, metabolic disorders, and cancers, as discussed below. This evidence concerns the gene CCR2 and metabolic disease.